Potential use of plant secondary metabolites in the treatment of allergic respiratory diseases (ARDs)
5
Issued Date
2025-12-01
Resource Type
ISSN
03014851
eISSN
15734978
Scopus ID
2-s2.0-105009227213
Journal Title
Molecular Biology Reports
Volume
52
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Molecular Biology Reports Vol.52 No.1 (2025)
Suggested Citation
Kang M., Yang K.M., Stanly C., Pant A. Potential use of plant secondary metabolites in the treatment of allergic respiratory diseases (ARDs). Molecular Biology Reports Vol.52 No.1 (2025). doi:10.1007/s11033-025-10770-2 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/111067
Title
Potential use of plant secondary metabolites in the treatment of allergic respiratory diseases (ARDs)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
The occurrence of allergic respiratory diseases (ARDs) is increasing worldwide due to hypersensitivity to foreign allergens. Around 40% of the global population is affected by ARDs which are exacerbated by environmental pollution. Furthermore, prolonged ARDs-associated symptoms reduce quality of life and increase the risk of neurological disorders like depression, anxiety disorder, and dementia through oxidative stress-induced neuroinflammation. Recently, plant secondary metabolites (PSMs) have emerged as novel dietary therapeutics, which exhibit potent antioxidant and antiallergic capabilities in treating ARDs. These bioactive compounds, have antimicrobial, antiviral, and antiallergic properties, making them particularly useful in treating respiratory diseases. This review summarizes and discusses the mechanisms of ARDs and how PSMs could be alternative therapeutics for treating ARDs, as well as prospects.